课题基金 / 基金详情

MITOTIC MODIFIERS OF HORMONE-DEPENDENT BREAST CANCER

MITOTIC MODIFIERS OF HORMONE-DEPENDENT BREAST CANCER
激素依赖性乳腺癌的有丝分裂修饰剂
批准号:
3093739
负责人:
ANDREA MANNI
金额:
$99.92万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 1996-07-31

项目摘要

项目成果

ANDREA MANNI的其他基金

相似基金

相关文献

中文摘要
翻译
乳腺癌是美国女性死亡的主要原因 在过去的十年里,它的发病率迅速上升。这 项目重点研究荷尔蒙的生物机制 控制细胞增殖,调节基因和表型 细胞改变,并影响肿瘤的侵袭和转移。 从最近的几个结果中得出的几个创新的新假说 我们的实验室将在拟议的研究中进行测试。突出显示 其中一些,我们认为结构性多胺合成可能 启动侵袭性肿瘤表型;胰岛素样生长因子 结合蛋白可能调节肿瘤细胞的增殖;该变体 孕激素受体可能对孕激素的作用产生负面影响; 中性粒细胞可能会在基底膜上造成洞,从而 肿瘤细胞穿透并侵袭组织;该肿瘤细胞可能 在缺乏雌激素的情况下,对雌二醇的敏感性增强。 该计划项目的总体目标是检查这些机制 它们改变了有丝分裂、细胞增殖和转移行为 乳腺癌细胞体外液体培养、动物体内生长 系统和自发地在患者体内。对这些的识别 机制应允许将治疗定向到特定的关键过程。 参与调查的调查人员的力量和专业知识 计划项目促进关注几个关键的监管步骤 包括多胺代谢(项目1)、胰岛素样生长因子 及其结合蛋白(项目2),孕激素受体生理学 和受体变异体(项目3),控制侵袭性的因素和 转移(项目4)与雌激素反应性的调节 (项目5)。实验通过直接处理可检验的假设 通过评估细胞变化来检查特定的分子过程, 并通过检测生物事件,如动物模型中的转移。 充分了解激素对有丝分裂过程的控制将 能够识别在以下过程中绕过的关键步骤 向侵袭性肿瘤表型进化。由这些数据产生的数据 研究应该允许选择几个关键的治疗步骤 干预。而对芳香酶的更彻底的阻断是一种趋势 作为优先事项,我们预计拟议的研究将确定其他几个步骤, 如鸟氨酸脱羧酶,作为治疗干预的靶点。
英文摘要
Breast cancer is the leading cause of death in women in the United States and its incidence has rapidly increased over the past decade. This Program Project focuses on the biologic mechanisms whereby hormones control cellular proliferation, modulate genotypic and phenotypic cellular changes, and influence tumor invasiveness and metastasis. Several innovative new hypotheses arising from recent results in several of our laboratories will be tested in the studies proposed. To highlight some of these, we propose that constitutive polyamine synthesis may initiate an aggressive tumor phenotype; that insulin-like growth factor binding proteins may modulate tumor cell proliferation; that variant progesterone receptors may exert negative effects on progestin action; that neutrophils may serve to create holes in basement membranes allowing tumor cells to penetrate and invade tissues; and that tumor cells may develop enhanced estradiol sensitivity upon estrogen deprivation. The overall goals of the Program Project are to examine the mechanisms which modify the mitotic, cell proliferative, and metastatic behavior of breast cancer cells growing in vitro in liquid culture, in vivo in animal systems and spontaneously in patients. Identification of these mechanisms should allow targeting of therapy to specific key processes. The strengths and expertise of the investigators participating in this Program Project facilitate focus on several key regulatory steps including polyamine metabolism (Project 1), insulin-like growth factors and their binding proteins (Project 2), progesterone receptor physiology and receptor variants (Project 3), factors controlling invasiveness and metastasis (Project 4), and regulation of responsiveness to estrogens (Project 5). Experiments address testable hypotheses by directly examining specific molecular processes, by evaluating cellular changes, and by examining biologic events such as metastases in animal models. A full understanding of the hormonal control of mitotic processes will enable identification of key steps which are bypassed in the process of evolution to aggressive tumor phenotypes. Data resulting from these studies should allow selection of several key steps for treatment intervention. While more complete blockade of aromatase is a current priority, we expect the proposed studies to identify several other steps, such as ornithine decarboxylase, as targets for therapeutic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Polyamines and Breast Cancer Biology
Polyamines and Breast Cancer Biology
Polyamines and Breast Cancer Biology
POLYAMINE INVOLVEMENT IN MAMMARY CARCINOGENESIS
海外基金